Gavin XIA, PhD

Chief Executive Officer and Co-Founder

  • A seasoned Entrepreneur and Venture Capitalist with over 15 years healthcare industry expertise for drug discovery and extensive management experience of Biotech start up companies
  • Undergraduate from Peking University, and PhD from University of Chicago


Chief Medical Officer and Co-Founder

  • A nephrologist with 15-year experience in academic and clinical practice, and over 18-year industry experience in Abbott and Roche focusing on clinical development
  • Oversaw the development and approval of Zemplar (Secondary hyperparathyroidism), Mircera (Renal anemia) and Actemra (Rheumatoid arthritis) in China
  • Graduated from Shanghai Second Military Medical University, completed his training in Internal Medicine at LAC-USC Medical Center and in Nephrology at Yale-New Haven Hospital. American Board-Certified Physician in Internal Medicine and Nephrology

Chutian SHU, PhD

Chief Technology Officer

  • Over 15-year industry experience in both MNCs (Boehringer Ingelheim and Novartis) and start-up commpanies, focusing on Chemical, Manufacturing and Control
  • Responsible for CMC research of several blockbuster drugs such as empagliflozin and the products in the development such as iptacopan
  • Graduated from University of Science and Technology of China, and PhD in Organic Chemistry from University of Emory

Huading Zhang, PhD

Chief Operation Officer

  • Over 15 years of industrial experience in both MNCs (Pfizer, Roche, Baxter and Amgen) and biotech (Cell Genesys), spanning in biologics CMC, clinical development, portofolio management & strategic planning
  • Graduated from Tsinghua University (bachelor of Engineering) and the Ohio State University (PhD in Bioengineering)


Chief of Staff

  • Over 15-year industry experience in Roche and other MNCs, focusing on organization development, talent management and compensation & benefits design in healthcare industry
  • Master of management, University of Hong Kong